Highlights from recent Life Science venture capital news. 28.03.2012 – Santa Barbara, CA Sientra Raises $65 Million in a Series C Financing Sientra, a privately-held medical device company focused on the aesthetic and plastic surgery markets, announced today that it closed on its $65 million Series C financing led by Abingworth and with participation [...]
Read more →Highlights from recent Life Science venture capital news. 13.03.2012 – Cleaveland, OH ViewRay Closes $45 million Round of Series C Financing ViewRay™ Incorporated, a privately held medical device company, has closed the final tranche of a $45 million round of Series C venture capital financing. Institutional investors include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, [...]
Read more →A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week. Total No. Deals NA EU Total Raised $ Total Raised € 47 35 12 240.2 182.0 North America No. Deals Total $ Total € Average $ Average € 35 192.1 145.7 [...]
Read more →Highlights from recent IT venture capital investment activity. North America First Venture Round 24.03.2012 – Los Angeles, CA The Honest Company Completes $27M Series A Financing The Honest Company, a Los Angeles, CA-based e-commerce site that offers non-toxic and natural baby and family products, has completed $27m Series A financing. Backers include General [...]
Read more →Highlights from recent Life Science venture capital news. Secondary Venture Round 21.03.2012 – Redwood City, CA Myoscience Closes $33 Million Series D Financing Myoscience, Inc., a Redwood City, California-based medical device company, has closed a $33m Series D financing. Backers include existing investors Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Medicis Capital, Nexus [...]
Read more →Highlights from recent IT venture capital investment activity. 15.03.2012 – Bellevue, WA Apptio raises $50M in new funding Apptio, moving further down the path toward a possible IPO, today announced a $50 million funding round led by T. Rowe Price — a significant injection of capital for the Seattle-area company and one of the largest [...]
Read more →A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week. Total No. Deals NA EU Total Raised $ Total Raised € 64 50 14 430.4 327.0 North America No. Deals Total $ Total € Average $ Average € 50 389.0 295.5 [...]
Read more →Highlights from recent IT venture capital investment activity. North America First Venture Round 05.03.2012 – Los Angeles, CA Nasty Gal Completes $9m Funding with Index Ventures Nasty Gal, a Los Angeles, CA-based fashion retail website for girls, has completed a $9m minority investment with Index Ventures’ Growth Fund. The company intends to invest the [...]
Read more →Highlights from recent Life Science venture capital news. First Venture Round 05.03.2012 – Medford, MA 4s3 Bioscience raises $20m Boston-based biotechnology company 4s3 Bioscience, Inc., which develops genetic disease therapies for orphan neuromuscular disorders, including some forms of muscular dystrophy, has raised $20 million in financing from KLP Enterprises LLC, a family-owned trust that owns [...]
Read more →Highlights from recent IT venture capital investment activity. Early Stage Venture Capital Investments 27.02.2012 – Mountain View, CA Game Closure Announces $12 Million in Series A Financing Led by Highland Capital Partners Game Closure today announced a Series A financing round of $12 million to fund its advanced HTML5-based cross-platform game technology. The round [...]
Read more →